Skip to main content

Eli Lilly (LLY) Stock Up Almost 50% Year to Date: Here's Why

Eli Lilly and Company (LLY​​​​​​​) boasts a solid portfolio of core drugs in diabetes, autoimmune diseases and cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.